GSK (GSK) Insider Trading & Ownership → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free GSK Stock Alerts $43.50 +0.15 (+0.35%) (As of 05/3/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media GSK (NYSE:GSK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.00%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$392.06 M Get GSK Insider Trade Alerts Want to know when executives and insiders are buying or selling GSK stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GSK Insider Buying and Selling by Quarter Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. GSK Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/16/2023Tommy TubervilleU.S. Congress Member (R-AL)Sell$36.59$1,001 - $15,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$33.85$15,001 - $50,0004/3/2023Tommy TubervilleU.S. Congress Member (R-AL)Buy$35.95$1,001 - $15,0003/1/2023Virginia FoxxU.S. Congress Member (R-NC)Sell$34.26$50,001 - $100,0008/16/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$35.26$1,001 - $15,0008/10/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$38.30$15,001 - $50,0008/9/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$40.03$1,001 - $15,0008/5/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$40.57$15,001 - $50,0007/12/2022Virginia FoxxU.S. Congress Member (R-NC)Sell$41.44$100,001 - $250,0007/6/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$43.11$1,001 - $15,0004/8/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$46.64$1,001 - $15,0002/22/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$42.69$1,001 - $15,0002/17/2022John H. RutherfordU.S. Congress Member (R-FL)Sell$43.32$1,001 - $15,0001/14/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$45.47$1,001 - $15,00010/8/2021Virginia FoxxU.S. Congress Member (R-NC)Buy$38.71$1,001 - $15,0007/9/2021Virginia FoxxU.S. Congress Member (R-NC)Buy$40.16$1,001 - $15,0006/4/2021Katherine M. ClarkU.S. Congress Member (D-MA)Sell$38.90$1,001 - $15,0006/4/2021Katherine M. ClarkU.S. Congress Member (D-MA)Sell$38.90$1,001 - $15,0005/20/2021Plc GlaxosmithklineMajor ShareholderSell32,005,260$12.25$392,064,435.00 (Data available from 1/1/2013 forward) GSK Insider Trading Activity - Frequently Asked Questions Who is on GSK's Insider Roster? The list of insiders at GSK includes Plc Glaxosmithkline. Learn more on insiders at GSK. What percentage of GSK stock is owned by insiders? 10.00% of GSK stock is owned by insiders. Learn more on GSK's insider holdings. Which members of congress are trading GSK? Tommy Tuberville (R-AL) and Daniel S. Goldman (D-NY) have sold shares of GSK in the last year totaling $40,500. More Insider Trading Tools from MarketBeat Related Companies: BMY Insider Ownership REGN Insider Ownership ZTS Insider Ownership VRTX Insider Ownership SNY Insider Ownership TAK Insider Ownership PFE Insider Ownership ABT Insider Ownership NVS Insider Ownership AZN Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NYSE:GSK) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.